Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Hypertriglyceridemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Large-scale testing (Phase 3)Study completedNCT01242527
What this trial is testing

Epanova® for Lowering Very High Triglycerides

Who this might be right for
Severe Hypertriglyceridemia
AstraZeneca 399
Large-scale testing (Phase 3)Active Not RecruitingNCT05681351
What this trial is testing

CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)

Who this might be right for
Severe Hypertriglyceridemia
Ionis Pharmaceuticals, Inc. 885
Large-scale testing (Phase 3)WithdrawnNCT04662528
What this trial is testing

Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL

Who this might be right for
Severe Hypertriglyceridemia
Matinas Biopharma, Inc
Large-scale testing (Phase 3)Active Not RecruitingNCT06347016
What this trial is testing

Study of Plozasiran in Adults With Severe Hypertriglyceridemia

Who this might be right for
Severe Hypertriglyceridemia
Arrowhead Pharmaceuticals 311
Large-scale testing (Phase 3)Study completedNCT04239950
What this trial is testing

Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia

Who this might be right for
Hypertriglyceridemia
Mochida Pharmaceutical Company, Ltd. 316
Not applicableLooking for participantsNCT03087253
What this trial is testing

The LD Lync Study - Natural History Study of Lipodystrophy Syndromes

Who this might be right for
Lipodystrophy (Genetic or Acquired, Non HIV)
University of Michigan 500
Large-scale testing (Phase 3)Study completedNCT05552326
What this trial is testing

Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

Who this might be right for
Severe Hypertriglyceridemia
Ionis Pharmaceuticals, Inc. 446
Testing effectiveness (Phase 2)Study completedNCT01208961
What this trial is testing

Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation

Who this might be right for
Severe Hypertriglyceridemia
AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT05355402
What this trial is testing

Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia

Who this might be right for
HypertriglyceridemiaAtherosclerotic Cardiovascular DiseaseSevere Hypertriglyceridemia
Ionis Pharmaceuticals, Inc. 154
Not applicableStudy completedNCT02622854
What this trial is testing

Plasma Exchange vs Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis

Who this might be right for
Acute Pancreatitis
University Medical Centre Ljubljana 22
Large-scale testing (Phase 3)Study completedNCT03001817
What this trial is testing

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

Who this might be right for
Severe Hypertriglyceridemia
Kowa Research Institute, Inc. 551
Not applicableStudy completedNCT04223908
What this trial is testing

InFocus France Epidemiological Study of Health Burden in Major Hypertriglyceridemia

Who this might be right for
Familial Chylomicronemia SyndromeMultifactorial Chylomicronemia Syndrome
New French Society of Atherosclerosis 52